ENVESTNET ASSET MANAGEMENT INC

Position in CRNX — Crinetics Pharmaceuticals, Inc.

CIK 1407543 Berwyn, PA

Position in CRNX

as of Mar 31, 2026 · filed May 4, 2026 Compact

Position Value

$5,471,934

-$596,463 QoQ

Shares Held

150,659

+15.6% QoQ

Ownership

0.143%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

ENVESTNET ASSET MANAGEMENT INC holds $767,534,926 across 109 Biotechnology names. CRNX ranks #23 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	503,564	$224,861,468
2	REGN	Regeneron Pharmaceuticals, Inc.	109,152	$84,335,201
3	ALNY	Alnylam Pharmaceuticals, Inc.	171,797	$56,842,473
4	INSM	INSMED Inc	299,925	$49,043,736
5	ARGX	Argenx SE	61,418	$44,850,494
6	RPRX	Royalty Pharma plc	495,892	$23,787,939
7	GMAB	Genmab A/S	862,301	$23,135,535
8	ROIV	Roivant Sciences Ltd.	678,518	$18,794,948

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,471,934	150,659	+15.6%	Shares	Sole	2026-05-04
2025-12-31	$6,068,397	130,363	+147.5%	Shares	Sole	2026-02-10
2025-09-30	$2,193,497	52,665	-2.9%	Shares	Sole	2025-11-05
2025-06-30	$1,560,460	54,258	-4.3%	Shares	Sole	2025-08-01
2025-03-31	$1,901,416	56,691	-10.1%	Shares	Sole	2025-04-29
2024-12-31	$3,225,127	63,077	+16.1%	Shares	Sole	2025-02-13
2024-09-30	$2,776,058	54,326	+4.9%	Shares	Sole	2024-11-07
2024-06-30	$2,319,718	51,791	+23.5%	Shares	Sole	2024-08-08
2024-03-31	$1,962,836	41,932	—	Shares	Sole	2024-05-13
No filing history on record for this holder in this stock.